Long-Term Outcomes after Conversion to a Belatacept-Based Immunosuppression in Kidney Transplant Recipients.
Gillian DivardOlivier AubertCharlotte Debiais-DeschampMarc RaynaudValentin GoutaudierMarta SablikCaroline SayegChristophe LegendreJulie ObertDany AnglicheauCarmen LefaucheurAlexandre LoupyPublished in: Clinical journal of the American Society of Nephrology : CJASN (2024)
Long-term Outcomes after Conversion to Belatacept, NCT04733131 .
Keyphrases